// App-Quantinova.ai

16348 2014 AHA : Ecto-Nucleotidase-Derived Adenosine Promotes Mineralization Through A2a Receptor in Calcified Aortic Valves Disease

Researchers

Presenter

  • Marie-Chloe Boulanger

Principal Investigators

  • Fayez Hadji

  • Rihab Bouchareb

  • Patrick Mathieu

  • CRIUCPQ

Medical Centers

  • CHUL, Quebec, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Calcific Aortic Valve Disease

Biomarkers

  • CREB-binding protein

  • Cyclic adenosine monophosphate

  • Cyclic AMP-dependent protein kinase

Drug/Treatment

  • Adenosine

  • Adenosine Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved